Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Kozarich John W sold 500 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 16, 2026
On Nov 12, 2026, Kozarich John W (Director) sold 500 Ligand Pharmaceuticals Incorporated shares at US$325.00 for US$163K under a trading plan, leaving 42,122 shares. Filed Nov 16, 2026 (Form 4).
- Sold
- 500 shares
- Price
- US$325.00
- Value
- US$163K
- Holding after
- 42,122 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock | Sale | 500 | US$325.00 | 42,122 | Direct |
Source
Download original · View original at SEC
Related
- Ligand Pharmaceuticals Incorporated
- Kozarich John W
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Kozarich John W · Jun 9, 2026
- Form 4 · Kozarich John W · May 14, 2026
- Form 4 · Kozarich John W · Apr 2, 2026
- Form 4 · Zimmermann Martine · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Form 4 · Aryeh Jason · Nov 12, 2026
- Schedule 13G/A · Invesco Ltd. · Nov 10, 2026
- Form 4 · Aryeh Jason · Nov 6, 2026